Advances in Research on Neurodegeneration

3 & 4

  • Y. Mizuno
  • M. B. H. Youdim
  • D. B. Calne
  • R. Horowski
  • W. Poewe
  • P. Riederer
Conference proceedings

Table of contents

  1. Front Matter
    Pages I-VIII
  2. K. Kojima, H. Wekerle, H. Lassmann, T. Berger, Ch. Linington
    Pages 43-51
  3. D. Teitelbaum, R. Arnon, M. Sela
    Pages 85-91
  4. K. P. Johnson
    Pages 111-115
  5. B. G. W. Arnason, A. Toscas, A. Dayal, Z. Qu, A. Noronha
    Pages 117-123
  6. K. P. Lesch, U. Balling, M. Seemann, A. Teufel, D. Bengel, A. Heils et al.
    Pages 155-167
  7. I. Ziv, D. Offen, A. Barzilai, R. Haviv, R. Stein, R. Zilkha-Falb et al.
    Pages 195-202
  8. T. Siddique, D. Nijhawan, A. Hentati
    Pages 219-233
  9. W. G. Tatton, R. M. E. Chalmers-Redman, W. Y. H. Ju, J. Wadia, N. A. Tatton
    Pages 245-268
  10. Back Matter
    Pages 277-283

About these proceedings


Neurodegeneration is one of the most important subjects of the investigation now and in the coming 21st century. Alzheimer's disease is the leading cause of dementia in the elderly people and Parkinson's disease is one of the major neurologic disorders with the prevalence between 1 and 2/1 000 population in advanced countries. Many others are suffering from intractable neurodegener­ ative disorders such as amyotrophic lateral sclerosis, Huntington's disease, or spinocerebellar degeneration. No truly effective treatment is available for any of these neurodegenerative disorders except for Parkinson's disease; even in Parkinson's disease, still it is impossible to slow down the disease process with the currently available treatment. It is urgently needed to develop new effective technique to halt or slow down the disease process in each of those disorders. Recent advance in the molecular biological and molecular genetic technique has brought us great progress in the understanding of etiology and pathogenesis of these disorders, but still it is not known how neurons are going to die in these disorders. To explore the question, mutual cooperation and exchange of ideas between basic scientists and clinical peoples are of utmost importance.


Alzheimer Parkinson alzheimer's disease cognition genetics molecular biology molecular genetics neurodegenerative disorders research

Editors and affiliations

  • Y. Mizuno
    • 1
  • M. B. H. Youdim
    • 2
  • D. B. Calne
    • 3
  • R. Horowski
    • 4
  • W. Poewe
    • 5
  • P. Riederer
    • 6
  1. 1.Department of NeurologyJuntendo UniversityTokyoJapan
  2. 2.Institute of PharmacologyTechnion — Israel Institute of TechnologyHaifaIsrael
  3. 3.Neurodegenerative Disorders CentreUniversity of British ColumbiaVancouverCanada
  4. 4.Clinical ResearchSchering AGBerlinFederal Republic of Germany
  5. 5.Department of NeurologyUniversity of InnsbruckAustria
  6. 6.Department of PsychiatryUniversity of WürzburgFederal Republic of Germany

Bibliographic information